Scarica l'app Stockscreener
7.98
0.62%
-0.05
Pre-mercato:
8.19
0.21
+2.63%
Precedente Chiudi:
$8.03
Aprire:
$7.84
Volume 24 ore:
944.28K
Relative Volume:
0.82
Capitalizzazione di mercato:
$494.16M
Reddito:
$170.16M
Utile/perdita netta:
$-312.76M
Rapporto P/E:
-1.404
EPS:
-5.6837
Flusso di cassa netto:
$-178.72M
1 W Prestazione:
+19.46%
1M Prestazione:
+18.93%
6M Prestazione:
-41.45%
1 anno Prestazione:
+1.66%
Intervallo 1D:
$7.75
$8.17
Intervallo di 1 settimana:
$6.79
$8.29
Portata 52W:
$5.37
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Nome
Ginkgo Bioworks Holdings Inc
Settore
Industria
Telefono
(877) 442-5362
Indirizzo
27 DRYDOCK AVENUE, BOSTON
Compare DNA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
7.98 | 497.25M | 170.16M | -312.76M | -178.72M | -5.6837 |
VRTX
Vertex Pharmaceuticals Inc
|
439.18 | 112.22B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.41 | 79.35B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
834.45 | 52.80B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
310.94 | 41.32B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
318.07 | 35.95B | 5.36B | 287.73M | 924.18M | 2.5229 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-15 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-05-10 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-02 | Downgrade | Goldman | Neutral → Sell |
| 2023-05-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Iniziato | Berenberg | Buy |
| 2022-10-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2022-02-23 | Iniziato | Goldman | Neutral |
| 2022-02-01 | Iniziato | BofA Securities | Neutral |
| 2022-01-28 | Iniziato | BofA Securities | Buy |
| 2022-01-07 | Iniziato | BTIG Research | Buy |
| 2021-11-29 | Iniziato | Jefferies | Buy |
| 2021-10-13 | Iniziato | Raymond James | Outperform |
| 2021-10-12 | Iniziato | William Blair | Outperform |
| 2021-09-20 | Iniziato | HSBC Securities | Buy |
Mostra tutto
Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie
Ginkgo Bioworks CFO Steven Coen sells $2,576 in shares - Investing.com
Ginkgo Bioworks (NYSE: DNA) officer sells shares to cover taxes after RSU vesting - Stock Titan
DNA (NYSE: DNA) Form 144: Proposed sale of 324 Class A shares, insider sales listed - Stock Titan
(DNA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
DNA (NYSE: DNA) Rule 144 shows insider resale notices totaling tens of thousands of shares - Stock Titan
Short Interest in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Decreases By 23.2% - MarketBeat
Is Ginkgo Bioworks Holdings (NYSE:DNA) In A Good Position To Deliver On Growth Plans? - Moomoo
Steven Coen Sells 33,171 Shares of Ginkgo Bioworks (NYSE:DNA) Stock - MarketBeat
Ginkgo Bioworks CFO Coen sells $212k in shares By Investing.com - Investing.com Australia
Ginkgo Bioworks CFO Coen sells $212k in shares - Investing.com
Ginkgo Bioworks (NYSE: DNA) CFO nets PSU shares, sells stock for taxes - Stock Titan
Ginkgo Bioworks (DNA) major shareholder sells $802k in stock By Investing.com - Investing.com South Africa
Ginkgo Bioworks (DNA) major shareholder sells $802k in stock - Investing.com
Ginkgo Bioworks (NYSE:DNA) Major Shareholder Barry Canton Sells 124,727 Shares - MarketBeat
PSU vesting drives tax share sale for Ginkgo Bioworks (DNA) holder - Stock Titan
Reshma Shetty of Ginkgo Bioworks (DNA) sells shares to cover tax after PSU vesting - Stock Titan
DNA (NYSE: DNA) files Form 144: 33,171 Class A shares tied to vesting - Stock Titan
Proposed Class A sale by DNA (NYSE: DNA) — Form 144 lists 40,893 shares - Stock Titan
Ginkgo Bioworks Announces Date of Second Quarter 2024 Results Pr - GuruFocus
Aug Reactions: Is Ginkgo Bioworks Holdings Inc a strong candidate for buy and hold2026 Update & Stepwise Trade Signal Guides - baoquankhu1.vn
Trading Action: Is Ginkgo Bioworks Holdings Inc part of any major index2026 Closing Moves & Advanced Technical Signal Analysis - baoquankhu1.vn
DNA SEC FilingsGinkgo Bioworks Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Ginkgo Bioworks (NYSE:DNA) Raised to "Hold" at Wall Street Zen - MarketBeat
Ginkgo Bioworks director Shetty sells $175k in shares By Investing.com - Investing.com Canada
Ginkgo Bioworks 10% owner Canton sells $175k in DNA stock - Investing.com Canada
Chart Watch: Can Ginkgo Bioworks Holdings Inc navigate macro headwindsPortfolio Performance Summary & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Ginkgo Bioworks CEO sells $1.37 million in shares By Investing.com - Investing.com South Africa
Jason Kelly Sells 109,767 Shares of Ginkgo Bioworks (NYSE:DNA) Stock - MarketBeat
Ginkgo Bioworks 10% owner Canton sells $175k in DNA stock By Investing.com - Investing.com South Africa
Ginkgo Bioworks CEO sells $1.37 million in shares - Investing.com
Ginkgo Bioworks director Shetty sells $175k in shares - Investing.com
Ginkgo Bioworks (NYSE:DNA) Insider Sells $91,164.15 in Stock - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Major Shareholder Sells $91,164.15 in Stock - MarketBeat
Insider Selling: Ginkgo Bioworks (NYSE:DNA) Major Shareholder Sells 13,116 Shares of Stock - MarketBeat
Tax-driven share sales follow PSU vesting at Ginkgo Bioworks (DNA) - Stock Titan
Tax-driven stock sales by major Ginkgo Bioworks (DNA) holder Barry Canton - Stock Titan
Ginkgo Bioworks (NYSE: DNA) insider vests PSUs, sells shares for taxes - Stock Titan
Director sales at DNA (NYSE: DNA) — 13,155 and 13,116 Class A shares - Stock Titan
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
DNA (NYSE: DNA) Form 144: 13,116 Class A shares proposed sale - Stock Titan
Jason Kelly to sell 109,767 Class A shares (NYSE: DNA) under Form 144 - Stock Titan
US Market Recap: Can Ginkgo Bioworks Holdings Inc maintain sales growthAnalyst Upgrade & Weekly Breakout Stock Alerts - baoquankhu1.vn
ProQR (PRQR) Partners with Ginkgo Bioworks to Boost AI-Driven Dr - GuruFocus
ProQR forms advisory board, partnership with Ginkgo as part of AI strategy - MSN
ProQR Forms AI Advisory Board and Partners with Ginkgo Bioworks - Intellectia AI
[144] Ginkgo Bioworks Holdings, Inc. SEC Filing - Stock Titan
ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event - GlobeNewswire Inc.
ProQR in pact with Ginkgo as part of AI strategy (PRQR:NASDAQ) - Seeking Alpha
ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board - Yahoo Finance
Aug Shorts: Is Ginkgo Bioworks Holdings Inc attractive for institutional investors2026 Analyst Calls & Weekly Setup with High ROI Potential - baoquankhu1.vn
Ginkgo Bioworks Divests Biosecurity Segment to Tower Biosecurity in Strategic Shift – Financial Impact and Pro Forma Results - Minichart
Ginkgo Bioworks Holdings Inc Azioni (DNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):